Want to join the conversation?
Pharmaceutical company $JNJ said its Janssen Biologics unit has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency for the use of subcutaneous SIMPONI in combination with methotrexate for the treatment of polyarticular juvenile idiopathic arthritis in children.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.